AtaiBeckley ATAI
NASDAQ ATAI
$7.39 +0.05 (+0.68%)
As of: Sep 4, 2026 · 3:59 PM EDT

AtaiBeckley (ATAI) Revenue (2021 - 2026)

AtaiBeckley (ATAI) posted Revenue of $749000.0 for Q3 2025, up 4.17% sequentially from $719000.0 in Q2 2025, and up 1772.5% YoY from $40000.0 in Q3 2024.

Analysis

AtaiBeckley (ATAI) Revenue (2021 - 2026) Analysis & Trends

AtaiBeckley has reported Revenue for 5 years, with the latest figure at $749000.0 in Q3 2025.

  • Quarterly Revenue rose 1772.5% year-over-year to $749000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $3.0 million (up 816.92% YoY) and the FY2024 annual result came in at $308000.0, down 1.91% from the prior year.
  • Revenue for Q1 2026 stood at $954000.0, down from $1.6 million in the prior quarter.
  • The five-year high for Revenue was $1.6 million in Q1 2025, with the low at $12000.0 in Q4 2024.
  • The 3-year median for Revenue is $954000.0 (2026), against an average of $840333.3.
  • The sharpest annual moves came in 2022 and 2025: Revenue slumped 90.98% in 2022, then jumped 1772.5% in 2025.
  • AtaiBeckley's Revenue stood at $12000.0 in 2024, then soared by 12858.33% to $1.6 million in 2025, then slumped by 38.65% to $954000.0 in 2026.
  • Business Quant data shows ATAI's Revenue at $954000.0 in Q1 2026, $1.6 million in Q1 2025, and $12000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 145.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.71 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.29 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 674.14 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 425.49 Mn
10 AtaiBeckley 1.61 Bn 1.61 Bn - 749,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.70 Mn
Mar 31, 2026 954,000.00
Sep 30, 2025 749,000.00
Jun 30, 2025 719,000.00
Jun 30, 2025 719,000.00
Mar 31, 2025 1.56 Mn
Mar 31, 2025 1.56 Mn
Dec 31, 2024 12,000.00
Dec 31, 2024 12,000.00
Sep 30, 2024 40,000.00
Jun 30, 2024 273,000.00
Dec 31, 2023 18,000.00
Sep 30, 2023 87,000.00
Jun 30, 2023 172,000.00
Mar 31, 2023 37,000.00
Dec 31, 2022 38,000.00
Sep 30, 2022 24,000.00
Jun 30, 2022 170,000.00
Dec 31, 2021 230,000.00
Sep 30, 2021 266,000.00